EUVIMEDEUVIMED entdecken
Crossref

Serum Interleukin-33 Levels and Their Association with Insulin Resistance and Hormonal Alterations in Women with Polycystic Ovary Syndrome: A Case–Control Study

Israa Jafar

International Journal of Environmental and Biological Sciences · 31.10.2026 · 1 (4)

DOI: 10.63939/sbe1vy96 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Environmental and Biological Sciences, online erschienen am 31.10.2026. Verfasst von Israa Jafar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Polycystic Ovary Syndrome (PCOS) is the most common endocrine disorder associated with metabolic imbalances and chronic inflammation. Interleukin-33 (IL-33) has been suggested as a biomarker for inflammation in a number of diseases. Aim of this study: To assess serum IL-33 levels in women with PCOS compared to healthy controls and to analyze its predictive capabilities as diagnostic marker for PCOS. Materials and Methods: A total of 180 women participated aged (18-40) years in the study included 90 newly diagnosed with PCOS and 90 healthy control groups in a case-control study. Serum IL-33 level was measured using an enzyme-linked immunosorbent assay. Clinical parameters such as BMI, fasting insulin (FIN) and homeostasis model assessment of insulin resistance (HOMA-IR) were measured. Besides IL-33 levels, clinical parameters such as LH, FSH, total testosterone and estradiol were also measured, and significant differences and correlations were obtained, which were all suggestive of metabolic and reproductive dysfunction associated with PCOS. The Receiver Operating Characteristic (ROC) curve analysis was used to determine the diagnostic value of IL-33 levels, and Random Forest and Support Vector Machine (SVM) classifiers were used to see how well the levels of IL-33 could predict the disease.

Results

The level of serum IL-33 was found to be significantly elevated in women with PCOS (75.4 ± 12.8 pg/mL) when compared with healthy controls (34.6 ± 8.5 pg/mL, p < 0.001). Positive correlations were observed between IL-33 level and BMI (r = 0.681,p

Zitieren

APA

Jafar, I. (2026). Serum Interleukin-33 Levels and Their Association with Insulin Resistance and Hormonal Alterations in Women with Polycystic Ovary Syndrome: A Case–Control Study. International Journal of Environmental and Biological Sciences, 1(4). https://doi.org/10.63939/sbe1vy96

Vancouver

Jafar I. Serum Interleukin-33 Levels and Their Association with Insulin Resistance and Hormonal Alterations in Women with Polycystic Ovary Syndrome: A Case–Control Study. International Journal of Environmental and Biological Sciences. 2026;1(4). doi:10.63939/sbe1vy96

BibTeX
@article{Jafar2026,
  author = {Jafar, Israa},
  title = {Serum Interleukin-33 Levels and Their Association with Insulin Resistance and Hormonal Alterations in Women with Polycystic Ovary Syndrome: A Case–Control Study},
  journal = {International Journal of Environmental and Biological Sciences},
  year = {2026},
  volume = {1},
  number = {4},
  doi = {10.63939/sbe1vy96}
}
Kostenlos starten →